Dr. Jorge Garcia has contributed to 3 publications.
Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial.
Rini, B. I.,Dorff, T. B.,Elson, P.,Rodriguez, C. S.,Shepard, D.,Wood, L.,Humbert, J.,Pyle, L.,Wong, Y. N.,Finke, J. H.,Rayman, P. A.,Larkin, J. M.,Garcia, J. A.,Plimac...; Lancet Oncol.. 2016 Aug 09.
See more >>
Response to post-axitinib treatment in patients with metastatic renal cell carcinoma.
Chittoria N, Haddad H, Elson P, Tannir NM, Wood LS, Dreicer R, Garcia JA, Rini BI, Jonasch E; BMC Cancer. 2016-03-29.
See more >>
A phase I/II study of lenalidomide in combination with sunitinib in patients with advanced or metastatic renal cell carcinoma.
Rini, B.,Redman, B.,Garcia, J. A.,Burris, H. A.,Li, S.,Fandi, A.,Beck, R.,Jungnelius, U.,Infante, J. R.; Ann. Oncol.. 2014 Jun 11.
See more >>